United Kingdom Bioinformatics Services Market Insight
United Kingdom Bioinformatics Services Market is growing at an 16.6% CAGR, driven by rising genomics research, increasing precision medicine adoption, expanding NHS digital health initiatives, and growing demand for data-driven drug discovery, improving healthcare research efficiency and clinical decision-making outcomes.
United Kingdom Bioinformatics Services Market Insights Forecasts to 2035
- The United Kingdom Bioinformatics Services Market Size Was Estimated at USD 206.3 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 16.6% from 2025 to 2035
- The United Kingdom Bioinformatics Services Market Size is Expected to Reach USD 958.6 Million by 2035
Notable Insights for United Kingdom Bioinformatics Services Market
- By service type, genomic data analysis services dominate, accounting for approximately 40–45% share in 2024, driven by rapid growth in sequencing projects.
- By application, drug discovery and development leads, holding around 35–40% share, supported by pharmaceutical R&D outsourcing.
- The UK is a global leader in genomics research, with over 2 million genomes sequenced through national initiatives, supporting large-scale bioinformatics adoption.
- Approximately 60% of biotech and pharmaceutical firms in the UK use external bioinformatics service providers for advanced data analysis.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Bioinformatics Services Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Bioinformatics Services Market
- Illumina Inc.
- Thermo Fisher Scientific
- QIAGEN
- IBM Corporation
- Oracle Corporation
- Eurofins Scientific
- DNAnexus
- BGI Genomics
- Others
Recent Developments:
- In April 2026, ISCB UK 2026 conference at Cambridge will unite bioinformatics and computational biology researchers, promoting collaboration, innovation, and advancements in data-driven life sciences and computational research.
- In June 2023, CLIMB-BIG-DATA expanded its UK bioinformatics infrastructure, strengthening cloud and HPC capabilities to support microbial genomics research, data analysis, and scalable bioinformatics services across UK institutions.
Market Segmentation:
United Kingdom Bioinformatics Services Market, By Service Type
- Genomic Data Analysis
- Proteomics & Metabolomics Analysis
- Sequence Alignment Services
- Data Management & Integration
United Kingdom Bioinformatics Services Market, By Application
- Drug Discovery & Development
- Clinical Diagnostics
- Agricultural Biotechnology
- Academic Research
United Kingdom Bioinformatics Services Market, By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Diagnostic Labs
Expert Views:
The UK Bioinformatics Services Market is expected to expand rapidly due to increasing genomic sequencing initiatives, rising adoption of precision medicine, and growing demand for AI-driven data analytics in healthcare research. Experts highlight that integration of bioinformatics with pharmaceutical R&D is accelerating drug discovery timelines and improving clinical outcomes. Strong government support through genomics programs and NHS digital transformation is further boosting market growth. Advancements in cloud computing, machine learning, and big data analytics are expected to play a critical role in shaping the future of bioinformatics services through 2035.